Bovie Gets FDA Approval For Kidney Surgery Device
MELVILLE, N.Y. (AP) ¿ Bovie Medical Corp. said Tuesday it received clearance to sell a device that cuts and reseals tissue in kidney surgeries.
The Food and Drug Administration approved market of Bovie's laparoscopic SEER device, which is used for cutting and coagulating soft tissue. It is intended to be used in partial removal of kidneys.
Bovie said the laparoscopic SEER, or Saline Enhance Electrosurgical Resection, device is an extension of a line the company launched earlier this year.
Bovie also said it filed for FDA approved of a line of coated blades and needles. The products are covered with a coating that resists scabbing and scar tissue caused by burning. The product line also includes coated ball electrodes.Shares of Bovie advanced 43 cents, or 5.4 percent, to $8.45 in afternoon trading.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV